Recent Trends in Cardiovascular Disease Mortality in Kazakhstan.
Kazakhstan
avoidable mortality
cardiovascular diseases
heart disease
trends
Journal
Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
05
2023
accepted:
11
08
2023
medline:
31
8
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
Cardiovascular diseases (CVD) are the leading cause of mortality in Kazakhstan. In the last decade, Kazakhstan has carried out a number of reforms in the healthcare sector, in particular, to reduce mortality from significant diseases, including CVD. This study aimed to provide the trend of avoidable mortality from CVD in Kazakhstan. We extracted data from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan on population by age; mortality rates from chronic rheumatic heart disease (I05-I09); hypertensive diseases (I10-I15); ischaemic heart disease (I20-I25); cerebrovascular diseases (I60-I69) from 2011 to 2021, by gender and 5-year age group (0, 1-4, 5-9, 74). We applied join point regression to calculate the average annual percentage change (AAPC). In addition, crude mortality and trends were calculated per 100,000 population. The avoidable mortality rates, including treatable and preventable mortality decreased between 2011 and 2019 and then increased in the last two years (2020 and 2021) in all four studied disease groups. The AAPC showed that total avoidable mortality rates decreased between 2011 and 2021-6.0 points (-10.6 to - 1.1) (p = 0.017), whereas in males -4.2 (-8.3 to 0.1) and females - 5.1 (-8.8 to -1.3) (p = 0.009). Avoidable mortality rates from ischemic heart disease, cerebrovascular and hypertensive disease has been reduced stronger in male compared to female. The crude mortality declined over the period given; however, among young people mortality is still high. Our findings showed that avoidable mortality from CVD decreased over the last years, which could be related to the policy on strengthening the primary care on early diagnosis and detection of CVD and its risk factors. However, primary healthcare facilities need to improve activities on health literacy (drug adherence, risk factors) of the population, including the prevention of CVD.
Identifiants
pubmed: 37645218
doi: 10.2147/VHRM.S417693
pii: 417693
pmc: PMC10461044
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
519-526Informations de copyright
© 2023 Junusbekova et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests in this work.
Références
Syst Rev. 2020 May 7;9(1):105
pubmed: 32381116
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Iran J Public Health. 2020 Jul;49(7):1269-1277
pubmed: 33083293
Ann Glob Health. 2020 Feb 26;86(1):21
pubmed: 32166066
JAMA Netw Open. 2022 Mar 1;5(3):e223872
pubmed: 35319764
Cent Asian J Glob Health. 2018 Aug 08;7(1):321
pubmed: 30863664
Bull World Health Organ. 2013 May 1;91(5):320-1
pubmed: 23678194
Popul Health Metr. 2017 Jul 1;15(1):23
pubmed: 28668081
Lancet. 2020 Jul 11;396(10244):97-109
pubmed: 32445693
Korean Circ J. 2015 May;45(3):202-9
pubmed: 26023308
BMC Public Health. 2018 Aug 6;18(1):975
pubmed: 30081871
Heart. 2021 Mar;107(5):373-380
pubmed: 33334865
Nagoya J Med Sci. 2012 Feb;74(1-2):51-61
pubmed: 22515111
Am J Mens Health. 2017 Sep;11(5):1501-1511
pubmed: 26614446
Curr Treat Options Cardiovasc Med. 2018 Aug 27;20(10):81
pubmed: 30146670
Iran J Public Health. 2022 Apr;51(4):821-830
pubmed: 35936532
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
N Engl J Med. 1976 Mar 11;294(11):582-8
pubmed: 942758
Swiss Med Wkly. 2017 Aug 14;147:w14478
pubmed: 28804861
Eur J Public Health. 2015 Oct;25(5):890-4
pubmed: 25745082
Prim Health Care Res Dev. 2019 Oct 21;20:e137
pubmed: 31630698
MMWR Morb Mortal Wkly Rep. 2013 Sep 6;62(35):721-7
pubmed: 24005227
Int J Health Policy Manag. 2022 Jun 01;11(6):820-828
pubmed: 33300765